Mirae Asset Global Investments’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7K | Buy |
1,921
+281
| +17% | +$3.18K | ﹤0.01% | 1388 |
|
|
2025
Q1 | $19.6K | Buy |
1,640
+17
| +1% | +$203 | ﹤0.01% | 1388 |
|
|
2024
Q4 | $13.8K | Buy |
1,623
+65
| +4% | +$554 | ﹤0.01% | 1475 |
|
|
2024
Q3 | $19.2K | Buy |
1,558
+298
| +24% | +$3.68K | ﹤0.01% | 1440 |
|
|
2024
Q2 | $15.2K | Sell |
1,260
-9,375
| -88% | -$113K | ﹤0.01% | 1424 |
|
|
2024
Q1 | $78.7K | Buy |
10,635
+375
| +4% | +$2.77K | ﹤0.01% | 2395 |
|
|
2023
Q4 | $126K | Buy |
+10,260
| New | +$126K | ﹤0.01% | 2418 |
|
|
2022
Q4 | – | Sell |
-10,014
| Closed | -$145K | – | 2564 |
|
|
2022
Q3 | $145K | Buy |
+10,014
| New | +$145K | ﹤0.01% | 2433 |
|